Loomis, Sayles & Company’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Sell |
2,105,409
-352,443
| -14% | -$3.97M | 0.03% | 208 |
|
|
2025
Q1 | $24.8M | Sell |
2,457,852
-1,213,159
| -33% | -$12.2M | 0.04% | 208 |
|
|
2024
Q4 | $43.4M | Sell |
3,671,011
-241,194
| -6% | -$2.85M | 0.05% | 136 |
|
|
2024
Q3 | $45.1M | Buy |
3,912,205
+458,601
| +13% | +$5.29M | 0.06% | 143 |
|
|
2024
Q2 | $36.5M | Buy |
3,453,604
+260,262
| +8% | +$2.75M | 0.05% | 165 |
|
|
2024
Q1 | $33.7M | Buy |
3,193,342
+639,712
| +25% | +$6.74M | 0.05% | 181 |
|
|
2023
Q4 | $28.7M | Buy |
2,553,630
+568,695
| +29% | +$6.39M | 0.04% | 208 |
|
|
2023
Q3 | $23.2M | Buy |
1,984,935
+24,428
| +1% | +$285K | 0.04% | 227 |
|
|
2023
Q2 | $19.8M | Buy |
+1,960,507
| New | +$19.8M | 0.03% | 252 |
|